US 12370261
Chimeric peptides for antisense delivery
granted A61KA61K47/545A61K47/64
Quick answer
US patent 12370261 (Chimeric peptides for antisense delivery) held by Sarepta Therapeutics, Inc. expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K47/545, A61K47/64, A61K47/645, A61K47/6455